RNA Connect, Inc. – Trademark Portfolio

Entity Type: 03

RNA Connect, Inc. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include MARATHONRT, RNACONNECT, and ULTRAMARATHONRT. The owner is based in Branford, CT.

23 Business Park Drive, Suite #1

Branford, CT 06405

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

RNA Connect, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does RNA Connect, Inc. have?

RNA Connect, Inc. has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.

What trademark classes does RNA Connect, Inc. file in?

RNA Connect, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are RNA Connect, Inc.'s most well-known trademarks?

RNA Connect, Inc.'s registered trademark portfolio includes well-known marks such as MARATHONRT, RNACONNECT, and ULTRAMARATHONRT. These are among 4 currently registered trademarks in the portfolio.

What is RNA Connect, Inc.'s trademark registration success rate?

RNA Connect, Inc. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.